IM Cannabis Corp. (IMCC.CN) Research

IM Cannabis Corp. is engaged in the cultivation, processing, and supply of medical cannabis products across its operational territories of Israel, Germany, and Canada. The company's product portfolio features cannabis flowers and distinctive, strain-specific extracts marketed under its IMC brand. Additionally, it offers dried flower, pre-rolls, and pressed hash through its WAGNERS and Highland Grow labels. IM Cannabis Corp. caters to a diverse customer base, including medical patients and adult-use recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Market snapshot

Symbol
IMCC.CN
Price
$5.10
Day change
-40.00%
Market cap
$17.2M
P/E ratio
-14.53x
52-week range
1.75-9.7
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Ayr Wellness Inc. (AYR-A.CN)
  • Chalice Brands Ltd. (CHAL.CN)
  • EXMceuticals Inc. (EXM.CN)
  • Marvell Technology, Inc. (MRV.TO)
  • Numinus Wellness Inc. (NUMI.TO)
  • Orion Nutraceuticals Inc. (ORI.CN)
  • Reunion Neuroscience Inc. (REUN.TO)
  • RIV Capital Inc. (RIV.CN)

Open IM Cannabis Corp. (IMCC.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.